- 全部删除
您的购物车当前为空
Quininib是一种选择性的CysLTR1和CysLTR2拮抗剂, IC50 分别为1.2和52μM,具有抗血管生成和抗肿瘤的作用。


为众多的药物研发团队赋能,
让新药发现更简单!
Quininib是一种选择性的CysLTR1和CysLTR2拮抗剂, IC50 分别为1.2和52μM,具有抗血管生成和抗肿瘤的作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 μg | ¥ 550 | In stock | |
| 1 mg | ¥ 790 | In stock | |
| 5 mg | ¥ 1,960 | In stock | |
| 10 mg | ¥ 2,980 | In stock | |
| 25 mg | ¥ 4,830 | In stock | |
| 50 mg | ¥ 6,720 | In stock | |
| 100 mg | ¥ 8,870 | In stock | |
| 200 mg | ¥ 12,200 | In stock |
Quininib 相关产品
| 产品描述 | Quininib is a selective antagonist of CysLTR1 and CysLTR2, with IC50 values of 1.2 and 52 μM, respectively, exhibiting anti-angiogenic and anti-tumour effects. |
| 靶点活性 | CysLT1:1.2 μM, CysLT2:52 μM |
| 分子量 | 247.29 |
| 分子式 | C17H13NO |
| CAS No. | 143816-42-6 |
| Smiles | C(=C/C1=C(O)C=CC=C1)\C2=NC3=C(C=C2)C=CC=C3 |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容